for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

BRIEF-Medicenna presents updates on phase 2b clinical trial of MDNA55 at annual meeting of society of neuro-oncology

Nov 16 (Reuters) - Medicenna Therapeutics Corp

* Medicenna presents updates on phase 2b clinical trial of MDNA55 at the annual meeting of the society of neuro-oncology Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up